0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 1152 results.
The global Biosimilar Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of...
Catalog:
GIR
January 2024
Price: USD 3,480.00
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Biosimilar Monoclonal Antibodies market size was valued at USD 4639.7 million in 2023 and is forecast to a readjusted size of USD 12580...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Adalimumab Biosimilars market size was valued at USD 23870 million in 2022 and is forecast to a readjusted size of USD 31050 million by...
Catalog:
GIR
December 2023
Price: USD 3,480.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Pertuzumab Biosimilars market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
December 2023
Price: USD 3,480.00
The global Interferon Alpha-2a Biosimilar market size was valued at USD 217.1 million in 2023 and is forecast to a readjusted size of USD 99.7...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones,...
Catalog:
MRRPB5
November 2023
Price: USD 4,350.00
The global Trastuzumab Biosimilars market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
December 2023
Price: USD 3,480.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Biosimilars Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The Biosimilar Development Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
